These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4184081)

  • 1. [Comparative evaluation of different methods of determination of heparin in blood and tolerance of plasma to heparin].
    Kalanov PI
    Lab Delo; 1968; 10():601-3. PubMed ID: 4184081
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin assay: a comparison between titrimetric and amidolytic methods.
    Nenci GG; Berrettini M; Agnelli G; Parise P
    Boll Soc Ital Biol Sper; 1980 Mar; 56(5):519-25. PubMed ID: 7387799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of heparin in blood].
    Barkagan ZS; Barkagan LZ
    Lab Delo; 1971; 6():331-5. PubMed ID: 4108743
    [No Abstract]   [Full Text] [Related]  

  • 4. Limitations of the activated partial thromboplastin time for determination of plasma heparin concentration and half-life in human subjects.
    Baele G; De Broe M; De Weerdt GA; Ringoir S; Barbier F
    Thromb Diath Haemorrh; 1972 Feb; 27(1):107-13. PubMed ID: 5033660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of heparin in blood plasma].
    Kotovshchikova MA; Krasko SS
    Lab Delo; 1974; 8(0):460-3. PubMed ID: 4139363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neutralization of the effect of heparin on coagulation tests in heparin plasma].
    Strässle R
    Med Lab (Stuttg); 1981 Dec; 34(12):338-42. PubMed ID: 7346709
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.
    Marder VJ
    Thromb Diath Haemorrh; 1970 Oct; 24(1):230-9. PubMed ID: 5483963
    [No Abstract]   [Full Text] [Related]  

  • 8. [Review: heparin. 1. Methods of determination and inhibitory mechanisms of some coagulation factors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):887-903. PubMed ID: 1713896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method of quantitative evaluation of the indices of blood plasma tolerance to heparin].
    Zolotukhin SI; Zagorskaia IB
    Farmakol Toksikol; 1967; 30(4):498-502. PubMed ID: 5598911
    [No Abstract]   [Full Text] [Related]  

  • 10. Standardized methods for heparin therapy.
    Soloway HB
    N Engl J Med; 1973 Aug; 289(8):429-30. PubMed ID: 4719832
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 12. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interaction of heparin-containing polymers with plasma and blood].
    Platé NA; Valuev LI; Gumirova FKh; Zimin NK; Rozenfel'd MA
    Vopr Med Khim; 1982; 28(3):97-101. PubMed ID: 7101821
    [No Abstract]   [Full Text] [Related]  

  • 14. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assays.
    Savidge GF; Kesteven PJ; Al-Hasani SF; O'Brien PF
    Thromb Haemost; 1983 Oct; 50(3):745-8. PubMed ID: 6648894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apparatus for automatic determination of blood tolerance to heparin].
    Lakin KM; Efimov VS; Barsukov II
    Farmakol Toksikol; 1970; 33(3):371-6. PubMed ID: 5453037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on plasma hypercoagulability. 3. An improved method for plasma heparin determination based on metachromatic activity and its levels in human plasma].
    Satake K
    Naika Hokan; 1969 May; 16(5):173-81. PubMed ID: 5387636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparin kinetics and methods of heparinization during haemodialysis (author's transl)].
    Lopot F
    Cas Lek Cesk; 1980 Feb; 119(5):139-44. PubMed ID: 7379103
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.